Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
Seth G S Medical College and KEM Hospital Mumbai
Eligibility
Inclusion criteria
Inclusion criteria: 1.Laboratory confirmed COVID 19 adults (Age > 18 years) admitted in KEM Hospital. 2.Patients in ICMR group 2B and onwards. 3.Received any of the following drugs alone or in combination: Remdesivir, Tocilizumab.
Exclusion criteria
Exclusion criteria: 1. Suspected COVID 19 patients. 2. Positive patients in category 1A to 2A 3. Pregnant/Lactating patients. 4. Mortality within 24 hours of admission.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)To assess the outcome of COVID 19 positive patients who have received Remdesivir or Tocilizumab or their combination. 2)To observe the clinical factors affecting the outcome. Timepoint: 1)1 month. 2)1 month. | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the duration of hospitalization, duration of oxygen therapy and duration required to bring about the change in the score of Ordinal scale for Clinical Improvement given by World Health Organization (WHO), until the final outcome. To observe for any adverse events, adverse drug reactions or any complications related to the standard treatment.Timepoint: 1 month | — |
Countries
India
Contacts
Public ContactDr Sushrut Ingawale
Seth GSMC and KEM Hospital, Mumbai
Outcome results
None listed